REPORT ID 10231

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Report 2017

Publish Date
16-Nov-17
Pages
113
Format
Electronic (PDF)

In this report, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies market competition by top manufacturers/players, with B-Cell Maturation Antigen(BCMA) Targeted Therapies sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Transposagen Biopharmaceuticals
    Sutro Biopharma
    Malin Corporation
    Eureka Therapeutics
    firstVentury Equity
    Five Prime Therapeutics
    Credit Suisse Securities
    Dana-Farber Cancer Institute
    Deerfield Partners
    Onyx Pharmaceuticals
    Juno Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Bispecific Antibodies
    Antibody Drug Conjugates
    Chimeric Antigen Receptor T-Cells
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Liver Cancer
    Respiratory Cancer
    Brain Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Market Report 2017
1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
    1.1 Product Overview and Scope of B-Cell Maturation Antigen(BCMA) Targeted Therapies
    1.2 Classification of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Product Category
        1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Bispecific Antibodies
        1.2.4 Antibody Drug Conjugates
        1.2.5 Chimeric Antigen Receptor T-Cells
    1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Application/End Users
        1.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Liver Cancer
        1.3.3 Respiratory Cancer
        1.3.4 Brain Cancer
        1.3.5 Others
    1.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Region
        1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
        1.4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
        1.4.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
        1.4.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
        1.4.6 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
        1.4.7 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of B-Cell Maturation Antigen(BCMA) Targeted Therapies (2012-2022)
        1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2022)
        1.5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2022)

2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Competition by Players/Suppliers, Type and Application
     2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Competition by Players/Suppliers
        2.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume and Value) by Type
        2.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share by Type (2012-2017)
        2.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Market Share by Type (2012-2017)
    2.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume and Value) by Region
        2.3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Market Share by Region (2012-2017)
        2.3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Market Share by Region (2012-2017)
    2.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume) by Application

3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    3.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        3.1.1 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        3.1.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        3.1.3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    3.2 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    3.3 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    3.4 United States B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    4.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        4.1.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        4.1.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        4.1.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    4.2 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    4.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    4.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

5 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    5.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        5.1.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        5.1.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        5.1.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    5.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    5.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    5.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

6 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    6.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        6.1.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        6.1.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        6.1.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    6.2 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    6.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    6.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

7 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    7.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        7.1.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    7.2 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    7.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    7.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

8 India B-Cell Maturation Antigen(BCMA) Targeted Therapies (Volume, Value and Sales Price)
    8.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Value (2012-2017)
        8.1.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales and Growth Rate (2012-2017)
        8.1.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate (2012-2017)
        8.1.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Price Trend (2012-2017)
    8.2 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Players
    8.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Type
    8.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales Volume and Market Share by Application

9 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Players/Suppliers Profiles and Sales Data
    9.1 Transposagen Biopharmaceuticals
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Sutro Biopharma
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Malin Corporation
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Eureka Therapeutics
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 firstVentury Equity
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Five Prime Therapeutics
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Credit Suisse Securities
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Dana-Farber Cancer Institute
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Deerfield Partners
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Onyx Pharmaceuticals
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Juno Therapeutics

10 B-Cell Maturation Antigen(BCMA) Targeted Therapies Maufacturing Cost Analysis
    10.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies
    10.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (2017-2022)
    14.1 G